Excipient specialist Colorcon buys an Indian rival, FDA gets tough on unapproved drugs plus facility updates from Farmar, ATMI and …
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

